Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Ultrastructural Features of Human Liver Specimens from Patients Who Died of Dengue Hemorrhagic Fever.

Win MM, Charngkaew K, Punyadee N, Aye KS, Win N, Chaisri U, Chomanee N, Avirutnan P, Yoksan S, Malasit P.

Trop Med Infect Dis. 2019 Apr 12;4(2). pii: E63. doi: 10.3390/tropicalmed4020063.

2.

Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: A case for further catch up campaigns?

Turtle L, Brindle HE, Schluter WW, Faragher B, Rayamajhi A, Bohara R, Gurung S, Shakya G, Yoksan S, Dixit S, Rajbhandari R, Paudel B, Adhikari S, Solomon T, Griffiths MJ.

PLoS Negl Trop Dis. 2019 Apr 15;13(4):e0007269. doi: 10.1371/journal.pntd.0007269. eCollection 2019 Apr.

3.

Hybridization Cascade Plus Strand-Displacement Isothermal Amplification of RNA Target with Secondary Structure Motifs and Its Application for Detecting Dengue and Zika Viruses.

Saisuk W, Srisawat C, Yoksan S, Dharakul T.

Anal Chem. 2019 Mar 5;91(5):3286-3293. doi: 10.1021/acs.analchem.8b03736. Epub 2019 Feb 11.

PMID:
30742406
4.

Serological Evidence of Japanese Encephalitis Virus Circulation in Asian Children From Dengue-Endemic Countries.

Nealon J, Taurel AF, Yoksan S, Moureau A, Bonaparte M, Quang LC, Capeding MR, Prayitno A, Hadinegoro SR, Chansinghakul D, Bouckenooghe A.

J Infect Dis. 2019 Jan 9;219(3):375-381. doi: 10.1093/infdis/jiy513.

5.

Complete Genome Sequence of a Zika Virus Strain Isolated from the Serum of an Infected Patient in Thailand in 2006.

Nitatpattana N, Chaiyo K, Rajakam S, Poolam K, Chansiprasert K, Pesirikan N, Buree S, Rodpai E, Yoksan S.

Genome Announc. 2018 Mar 8;6(10). pii: e00121-18. doi: 10.1128/genomeA.00121-18.

6.

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children.

Chanthavanich P, Limkittikul K, Sirivichayakul C, Chokejindachai W, Hattasingh W, Pengsaa K, Surangsrirat S, Srisuwannaporn T, Kaewma B, Yoksan S, Jun G, Zhumu B.

Hum Vaccin Immunother. 2018 Apr 3;14(4):900-905. doi: 10.1080/21645515.2017.1414763. Epub 2018 Jan 16.

7.

The synergistic effect of nsP2-L618, nsP3-R117, and E2-K187 on the large plaque phenotype of chikungunya virus.

Thoka B, Jaimipak T, Onnome S, Yoksan S, Ubol S, Pulmanausahakul R.

Virus Genes. 2018 Feb;54(1):48-56. doi: 10.1007/s11262-017-1524-1. Epub 2017 Nov 28.

PMID:
29185115
8.

Marmosets (Callithrix jacchus) as a non-human primate model for evaluation of candidate dengue vaccines: induction and maintenance of specific protective immunity against challenges with clinical isolates.

Moi ML, Ami Y, Muhammad Azami NA, Shirai K, Yoksan S, Suzaki Y, Kitaura K, Lim CK, Saijo M, Suzuki R, Takasaki T, Kurane I.

J Gen Virol. 2017 Dec;98(12):2955-2967. doi: 10.1099/jgv.0.000913. Epub 2017 Nov 21.

PMID:
29160199
9.

Differences in activation and tissue homing markers of natural killer cell subsets during acute dengue infection.

Keawvichit R, Khowawisetsut L, Lertjuthaporn S, Tangnararatchakit K, Apiwattanakul N, Yoksan S, Chuansumrit A, Chokephaibulkit K, Ansari AA, Onlamoon N, Pattanapanyasat K.

Immunology. 2018 Apr;153(4):455-465. doi: 10.1111/imm.12858. Epub 2017 Dec 11.

10.

Small plaque size variant of chikungunya primary isolate showed reduced virulence in mice.

Jaimipak T, Yoksan S, Ubol S, Pulmanausahakul R.

Asian Pac J Allergy Immunol. 2018 Sep;36(3):201-205. doi: 10.12932/AP-250417-0079.

11.

Rapid and accurate interpretation of dengue diagnostics in the context of dengue vaccination implementation: Viewpoints and guidelines issued from an experts group consultation.

Hunsperger EA, Duarte Dos Santos CN, Vu HTQ, Yoksan S, Deubel V.

PLoS Negl Trop Dis. 2017 Sep 7;11(9):e0005719. doi: 10.1371/journal.pntd.0005719. eCollection 2017 Sep. No abstract available.

12.

Involvement of fatty acid synthase in dengue virus infection.

Tongluan N, Ramphan S, Wintachai P, Jaresitthikunchai J, Khongwichit S, Wikan N, Rajakam S, Yoksan S, Wongsiriroj N, Roytrakul S, Smith DR.

Virol J. 2017 Feb 13;14(1):28. doi: 10.1186/s12985-017-0685-9.

13.

Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV Immunization.

Feroldi E, Boaz M, Yoksan S, Chokephaibulkit K, Thisyakorn U, Pancharoen C, Monfredo C, Bouckenooghe A.

J Infect Dis. 2017 Jan 15;215(2):221-227. doi: 10.1093/infdis/jiw533.

14.

Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine.

Wijesinghe PR, Abeysinghe MRN, Yoksan S, Yao Y, Zhou B, Zhang L, Fleming JA, Marfin AA, Victor JC.

Vaccine. 2016 Nov 21;34(48):5923-5928. doi: 10.1016/j.vaccine.2016.10.028. Epub 2016 Oct 20.

15.

Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.

Janewongwirot P, Puthanakit T, Anugulruengkitt S, Jantarabenjakul W, Phasomsap C, Chumket S, Yoksan S, Pancharoen C.

Vaccine. 2016 Oct 17;34(44):5279-5283. doi: 10.1016/j.vaccine.2016.09.005. Epub 2016 Sep 12.

PMID:
27628323
16.

Human T cell responses to Japanese encephalitis virus in health and disease.

Turtle L, Bali T, Buxton G, Chib S, Chan S, Soni M, Hussain M, Isenman H, Fadnis P, Venkataswamy MM, Satishkumar V, Lewthwaite P, Kurioka A, Krishna S, Shankar MV, Ahmed R, Begum A, Ravi V, Desai A, Yoksan S, Fernandez S, Willberg CB, Kloverpris HN, Conlon C, Klenerman P, Satchidanandam V, Solomon T.

J Exp Med. 2016 Jun 27;213(7):1331-52. doi: 10.1084/jem.20151517. Epub 2016 May 30.

17.

Correction for Okabayashi et al., Detection of Chikungunya Virus Antigen by a Novel Rapid Immunochromatographic Test.

Okabayashi T, Sasaki T, Masrinoul P, Chantawat N, Yoksan S, Nitatpattana N, Chusri S, Morales Vargas RE, Grandadam M, Brey PT, Soegijanto S, Mulyantno KC, Churrotin S, Kotaki T, Faye O, Faye O, Sow A, Sall AA, Puiprom O, Chaichana P, Kurosu T, Kato S, Kosaka M, Ramasoota P, Ikuta K.

J Clin Microbiol. 2016 Apr;54(4):1173-4. doi: 10.1128/JCM.03073-15. No abstract available.

18.

Immunological evidence of Zika virus transmission in Thailand.

Wikan N, Suputtamongkol Y, Yoksan S, Smith DR, Auewarakul P.

Asian Pac J Trop Med. 2016 Feb;9(2):141-4. doi: 10.1016/j.apjtm.2016.01.017. Epub 2016 Jan 13.

19.

Generation and preclinical immunogenicity study of dengue type 2 virus-like particles derived from stably transfected mosquito cells.

Suphatrakul A, Yasanga T, Keelapang P, Sriburi R, Roytrakul T, Pulmanausahakul R, Utaipat U, Kawilapan Y, Puttikhunt C, Kasinrerk W, Yoksan S, Auewarakul P, Malasit P, Charoensri N, Sittisombut N.

Vaccine. 2015 Oct 13;33(42):5613-5622. doi: 10.1016/j.vaccine.2015.08.090. Epub 2015 Sep 14.

PMID:
26382602
20.

Delayed antibody dependent enhancement of low passage dengue virus 4 isolates.

Wikan N, Libsittikul S, Yoksan S, Auewarakul P, Smith DR.

BMC Res Notes. 2015 Sep 2;8:399. doi: 10.1186/s13104-015-1381-8.

21.

Retrospective screening of acute undifferentiated fever serum samples with universal flavivirus primers.

Khongwichit S, Libsittikul S, Yoksan S, Auewarakul P, Suputtamongkol Y, Smith DR.

J Infect Dev Ctries. 2015 Jul 30;9(7):760-4. doi: 10.3855/jidc.5866.

22.

Evidence of plasticity in the dengue virus: Host cell interaction.

Rungruengphol C, Jaresitthikunchai J, Wikan N, Phaonakrop N, Keadsanti S, Yoksan S, Roytrakul S, Smith DR.

Microb Pathog. 2015 Sep;86:18-25. doi: 10.1016/j.micpath.2015.07.003. Epub 2015 Jul 4.

PMID:
26151372
23.

High Anti-Dengue Virus Activity of the OAS Gene Family Is Associated With Increased Severity of Dengue.

Simon-Loriere E, Lin RJ, Kalayanarooj SM, Chuansumrit A, Casademont I, Lin SY, Yu HP, Lert-Itthiporn W, Chaiyaratana W, Tangthawornchaikul N, Tangnararatchakit K, Vasanawathana S, Chang BL, Suriyaphol P, Yoksan S, Malasit P, Despres P, Paul R, Lin YL, Sakuntabhai A.

J Infect Dis. 2015 Dec 15;212(12):2011-20. doi: 10.1093/infdis/jiv321. Epub 2015 Jun 10.

PMID:
26063222
24.

Dengue vaccine--time to act now.

Pang T, Thiam DGY, Tantawichien T, Ismail Z, Yoksan S.

Lancet. 2015 May 2;385(9979):1725-1726. doi: 10.1016/S0140-6736(15)60888-1. No abstract available.

PMID:
25943934
25.

Vascular leakage in dengue hemorrhagic Fever is associated with dengue infected monocytes, monocyte activation/exhaustion, and cytokines production.

Chunhakan S, Butthep P, Yoksan S, Tangnararatchakit K, Chuansumrit A.

Int J Vasc Med. 2015;2015:917143. doi: 10.1155/2015/917143. Epub 2015 Feb 5.

26.

Dengue virus infection of erythroid precursor cells is modulated by both thalassemia trait status and virus adaptation.

Sornjai W, Khungwanmaythawee K, Svasti S, Fucharoen S, Wintachai P, Yoksan S, Ubol S, Wikan N, Smith DR.

Virology. 2014 Dec;471-473:61-71. doi: 10.1016/j.virol.2014.10.004. Epub 2014 Oct 25.

27.

Detection of chikungunya virus antigen by a novel rapid immunochromatographic test.

Okabayashi T, Sasaki T, Masrinoul P, Chantawat N, Yoksan S, Nitatpattana N, Chusri S, Morales Vargas RE, Grandadam M, Brey PT, Soegijanto S, Mulyantno KC, Churrotin S, Kotaki T, Faye O, Faye O, Sow A, Sall AA, Puiprom O, Chaichana P, Kurosu T, Kato S, Kosaka M, Ramasoota P, Ikuta K.

J Clin Microbiol. 2015 Feb;53(2):382-8. doi: 10.1128/JCM.02033-14. Epub 2014 Nov 19. Erratum in: J Clin Microbiol. 2016 Apr;54(4):1173-4.

28.

Long-term persistence of Chikungunya virus neutralizing antibodies in human populations of North Eastern Thailand.

Nitatpattana N, Kanjanopas K, Yoksan S, Satimai W, Vongba N, Langdatsuwan S, Nakgoi K, Ratchakum S, Wauquier N, Souris M, Auewarakul P, Gonzalez JP.

Virol J. 2014 Oct 21;11:183. doi: 10.1186/1743-422X-11-183.

29.

Evaluation of commercially available diagnostic tests for the detection of dengue virus NS1 antigen and anti-dengue virus IgM antibody.

Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, Enria DA, Vazquez S, Cartozian E, Pelegrino JL, Artsob H, Guzman MG, Olliaro P, Zwang J, Guillerm M, Kliks S, Halstead S, Peeling RW, Margolis HS.

PLoS Negl Trop Dis. 2014 Oct 16;8(10):e3171. doi: 10.1371/journal.pntd.0003171. eCollection 2014 Oct.

30.

Immunogenicity of a live-attenuated Japanese encephalitis vaccine in children and adolescents after hematopoietic stem cell transplantation.

Pakakasama S, Wattanatitan S, Techasaensiri C, Yoksan S, Sirireung S, Hongeng S.

Bone Marrow Transplant. 2014 Oct;49(10):1307-9. doi: 10.1038/bmt.2014.149. Epub 2014 Jul 21.

PMID:
25046215
31.

Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation.

Kwissa M, Nakaya HI, Onlamoon N, Wrammert J, Villinger F, Perng GC, Yoksan S, Pattanapanyasat K, Chokephaibulkit K, Ahmed R, Pulendran B.

Cell Host Microbe. 2014 Jul 9;16(1):115-27. doi: 10.1016/j.chom.2014.06.001. Epub 2014 Jun 26.

32.

Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka.

Wijesinghe PR, Abeysinghe MR, Yoksan S, Yao Y, Zhou B, Zhang L, Yaich M, Neuzil KM, Victor JC.

Vaccine. 2014 Aug 20;32(37):4751-7. doi: 10.1016/j.vaccine.2014.06.036. Epub 2014 Jun 18.

33.

Preparing for dengue vaccine introduction in ASEAN countries: recommendations from the first ADVA regional workshop.

Thisyakorn U, Capeding MR, Goh DY, Hadinegoro SR, Ismail Z, Tantawichien T, Yoksan S, Pang T.

Expert Rev Vaccines. 2014 May;13(5):581-7. doi: 10.1586/14760584.2014.907529. Epub 2014 Apr 4. Review.

PMID:
24702301
34.

Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India.

Bonaparte M, Dweik B, Feroldi E, Meric C, Bouckenooghe A, Hildreth S, Hu B, Yoksan S, Boaz M.

BMC Infect Dis. 2014 Mar 21;14:156. doi: 10.1186/1471-2334-14-156.

35.

Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand.

Sirivichayakul C, Sabchareon A, Limkittikul K, Yoksan S.

Virol J. 2014 Mar 12;11:48. doi: 10.1186/1743-422X-11-48.

36.

Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.

Erra EO, Askling HH, Yoksan S, Rombo L, Riutta J, Vene S, Lindquist L, Vapalahti O, Kantele A.

Vaccine. 2013 Dec 17;32(1):119-23. doi: 10.1016/j.vaccine.2013.10.055. Epub 2013 Oct 28.

37.

Dengue, Japanese encephalitis and Chikungunya virus antibody prevalence among captive monkey (Macaca nemestrina) colonies of Northern Thailand.

Nakgoi K, Nitatpattana N, Wajjwalku W, Pongsopawijit P, Kaewchot S, Yoksan S, Siripolwat V, Souris M, Gonzalez JP.

Am J Primatol. 2014 Jan;76(1):97-102. doi: 10.1002/ajp.22213. Epub 2013 Sep 16.

PMID:
24105916
38.

Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage.

Keelapang P, Nitatpattana N, Suphatrakul A, Punyahathaikul S, Sriburi R, Pulmanausahakul R, Pichyangkul S, Malasit P, Yoksan S, Sittisombut N.

Vaccine. 2013 Oct 17;31(44):5134-40. doi: 10.1016/j.vaccine.2013.08.027. Epub 2013 Aug 22.

PMID:
23973247
39.

Tumour necrosis factor gene polymorphism in dengue infection: association with risk of bleeding.

Chuansumrit A, Anantasit N, Sasanakul W, Chaiyaratana W, Tangnararatchakit K, Butthep P, Chunhakan S, Yoksan S.

Paediatr Int Child Health. 2013 May;33(2):97-101. doi: 10.1179/2046905512Y.0000000049.

PMID:
23925283
40.
41.

Dengue infection in hematologic-oncologic pediatric patients: aggravation of anemia and bleeding risk.

Chuansumrit A, Tangnararatchakit K, Sirachainan N, Pakakasamal S, Hongeng S, Chaiyaratana W, Kitpoka P, Yoksan S.

Southeast Asian J Trop Med Public Health. 2012 Mar;43(2):311-22.

PMID:
23082583
42.

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes.

Erra EO, Askling HH, Yoksan S, Rombo L, Riutta J, Vene S, Lindquist L, Vapalahti O, Kantele A.

Clin Infect Dis. 2013 Jan;56(2):267-70. doi: 10.1093/cid/cis883. Epub 2012 Oct 16.

43.

Cardiovascular change in children with dengue shock syndrome.

Khositseth A, Tangnararatchakit K, Chuansumrit A, Wanitkun S, Kuptanon T, Chaiyaratana W, Yoksan S.

J Pediatr Intensive Care. 2012 Sep;1(3):153-160. doi: 10.3233/PIC-2012-025.

44.

Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever.

Butthep P, Chunhakan S, Yoksan S, Tangnararatchakit K, Chuansumrit A.

Pediatr Infect Dis J. 2012 Dec;31(12):e232-8. doi: 10.1097/INF.0b013e31826fd456.

PMID:
22926216
45.

A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines.

Erra EO, Askling HH, Rombo L, Riutta J, Vene S, Yoksan S, Lindquist L, Pakkanen SH, Huhtamo E, Vapalahti O, Kantele A.

Clin Infect Dis. 2012 Sep;55(6):825-34. doi: 10.1093/cid/cis542. Epub 2012 Jun 13.

46.

Severe nonfebrile dengue infection in an adolescent after postoperative kidney transplantation: a case report.

Tangnararatchakit K, Tirapanich W, Tapaneya-Olarn W, Sumethkul V, Sirachainan N, Watcharananan S, Leenanupunth C, Yoksan S, Chuansumrit A.

Transplant Proc. 2012 Jan;44(1):303-6. doi: 10.1016/j.transproceed.2011.11.025.

PMID:
22310639
47.

Infection-associated hemophagocytic syndrome among patients with dengue shock syndrome and invasive aspergillosis: a case series and review of the literature.

Larbcharoensub N, Aroonroch R, Kanoksil W, Leopairut J, Nitiyanant P, Khositseth A, Tangnararatchakit K, Chuansumrit A, Yoksan S.

Southeast Asian J Trop Med Public Health. 2011 Sep;42(5):1106-12. Review.

PMID:
22299436
48.

Chikungunya virus infection of cell lines: analysis of the East, Central and South African lineage.

Wikan N, Sakoonwatanyoo P, Ubol S, Yoksan S, Smith DR.

PLoS One. 2012;7(1):e31102. doi: 10.1371/journal.pone.0031102. Epub 2012 Jan 27.

49.

Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans.

Wrammert J, Onlamoon N, Akondy RS, Perng GC, Polsrila K, Chandele A, Kwissa M, Pulendran B, Wilson PC, Wittawatmongkol O, Yoksan S, Angkasekwinai N, Pattanapanyasat K, Chokephaibulkit K, Ahmed R.

J Virol. 2012 Mar;86(6):2911-8. doi: 10.1128/JVI.06075-11. Epub 2012 Jan 11.

50.

Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.

Chotpitayasunondh T, Sohn YM, Yoksan S, Min J, Ohrr H.

J Med Assoc Thai. 2011 Aug;94 Suppl 3:S195-203.

PMID:
22043776

Supplemental Content

Loading ...
Support Center